Article Information
History
- February 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- B.R. Ansila,*,
- Carolin Elizabeth Georgeb,
- Sindhulina Chandrasinghc,
- Ashwin Viswanathand,
- Mukund Thattaia,
- Padinjat Raghua,
- Santhosha Devadigae,
- Arun Geetha Harikumare,
- Pulleri Kandi Harshae,
- Indu Nairf,
- Uma Ramakrishnana,* and
- Satyajit Mayora
- aNational Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, India 560065
- bCommunity Health and Research Division, Bangalore Baptist Hospital, Bangalore, Karnataka, India 560024
- cDepartment of Microbiology, Bangalore Baptist Hospital, Bangalore, Karnataka, India 560024
- dNature Conservation Foundation, Mysore, Karnataka, India 570017
- eCOVID-19 Testing Laboratory, Institute for Stem Cell Science and Regenerative Medicine, Bangalore Life Science Cluster, Bangalore, Karnataka, India 560065
- fDepartment of Medicine and Infectious diseases, Bangalore Baptist Hospital, Bangalore, Karnataka, India 560024
- ↵*Corresponding author:
ansilbr{at}ncbs.res.in (ABR); uramakri{at}ncbs.res.in (UR)
Posted February 08, 2022.
Validating saliva as a biological sample for cost-effective, rapid and routine screening for SARS-CoV-2
